MIS® Implants Technologies and NBMolecules® conclude a License and Supply Agreement for use of the novel technology SurfLink® for treatment of MIS dental implants

The unique bio-mimicking traits and the cost-effectiveness of the SurfLink® surface treatment are clear differentiators from all competing solutions.

BAR LEV (IL) and GLAND (CH) July 27, 2015 – MIS Implants Technologies Ltd and Nano Bridging Molecules SA announced today they have concluded a License and Supply Agreement for the advanced surface treatment technology SurfLink®, manufactured by NBMolecules®. “We are very proud of this commercial agreement with MIS, which will allow patients to benefit from the unique combination of a leading quality dental implant and a unique bio-mimicking surface” says Bjorn-Owe Aronsson, Executive Director and Founder of NBMolecules®.

The agreement between the world leading dental implant company MIS and the start-up NBMolecules® will give MIS the exclusive rights to manufacture and sell their titanium based dental implants with the clinically proven SurfLink® surface.

SurfLink® consists of a permanently bound layer of phosphorous-rich molecules, which is applied to the implant surface to enhance osseointegration. The SurfLink® surface is seen as bone-like by the body.

Clinical studies have shown SurfLink® maintains marginal bone levels over time, giving reproducible clinical results and predictable osseointegration.

MIS, a frontrunner of innovation, is committed to achieve the highest possible implant surface quality to give patients the best that science can offer. “This agreement with NBMolecules® is an important stage in our efforts to offer our customers real innovation, based on cutting edge and proven technology. It will allow us to give our dental surgeons access to truly world leading dental implants” says Idan Kleifeld, CEO of MIS.

About MIS Implants Technologies Ltd.

Established in 1995, MIS Implants Technologies Ltd. is a global leader in the development and production of advanced products and innovative solutions aimed to simplify implants dentistry. Through state-of-the-art production facilities, MIS offers a comprehensive range of cutting-edge dental implants, superstructures, tools and kits, as well as extensive solutions for oral restoration and health.

MIS is deeply committed to its core values of quality, service, agility and innovation, integrity and caring, reflected in every step of its work process and supported by over 400 dedicated MIS employees. MIS products are distributed in over 60 countries worldwide through a well-established global distribution network.

About Nano Bridging Molecules SA

NBMolecules®, a privately held Swiss Medical Device company founded in 2002, is dedicated to developing and licensing out advanced surface treatments for bone anchored implants. NBMolecules® is ISO 13485 certified and SurfLink® is its first surface technology, which is manufactured in-house. SurfLink® has been developed over a period of 15 years and has been proven to achieve true bone integration. NBMolecules® is committed to excellence in both science and product quality. A small core team manages the NBM’s day to day business. Over 65 contracts with research institutions and other external service providers have been established, and the company continues to grow.

For more information, please visit www.NBMolecules.com and www.MIS-implants.com or

Contact:

Bjorn-Owe Aronsson
Nano Bridging Molecules SA
info@NBMolecules.com